Esther Castellano
- Molecular Biology top 5%
- Protein Kinase Regulation and GTPase Signaling 9
- PI3K/AKT/mTOR signaling in cancer 8
- Melanoma and MAPK Pathways 2
- Cell death mechanisms and regulation 2
- Oncology top 5%
- Cancer-related Molecular Pathways 5
- Cytokine Signaling Pathways and Interactions 4
- Cancer Research top 10%
- Cell Biology top 5%
- Microtubule and mitosis dynamics 2
- Genetics top 10%
-
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Julian DownwardEugenio SantosLuis Miguel Pedrero EstebanMatthias DrostenMariano BarbacidEleanor Y. M. SumJelena UrosevicCarmen Guerra
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Investigation (1 paper)Nature Communications (2 papers)
- Partner nations
- SpainUnited KingdomAustria
In The Last Decade
Esther Castellano
19 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Molecular Biology 1.3k
- Oncology 458
- Cancer Research 243
- Cell Biology 223
- Genetics 84
Countries citing papers authored by Esther Castellano
This map shows the geographic impact of Esther Castellano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Castellano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Castellano more than expected).
Fields of papers citing papers by Esther Castellano
This network shows the impact of papers produced by Esther Castellano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Castellano. The network helps show where Esther Castellano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esther Castellano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 15 | |
| 5 | 2021 | 65 | |
| 6 | 2021 | 54 | |
| 7 | 2017 | 53 | |
| 8 | 2016 | 53 | |
| 9 | 2015 | 32 | |
| 10 | 2014 | 66 | |
| 11 | 2013 | 139 | |
| 12 | 2013 | 5 | |
| 13 | 2011 | 211 | |
| 14 | RAS Interaction with PI3K: More Than Just Another Effector Pathwaybreakdown → | 2011 | 549 |
| 15 | 2011 | 33 | |
| 16 | 2010 | 98 | |
| 17 | 2010 | 243 | |
| 18 | 2009 | 15 | |
| 19 | 2006 | 32 | |
| 20 | 2006 | 35 |
About Esther Castellano
Esther Castellano is a scholar working on Oncology, Developmental Neuroscience and Molecular Biology, having authored 20 papers that have together received 1.7k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer-related Molecular Pathways (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Microtubule and mitosis dynamics (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Melanoma and MAPK Pathways (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Oncology (458 citations) and Cancer Research (243 citations). Esther Castellano has collaborated with scholars based in Spain, United Kingdom and Austria. Frequent co-authors include Julian Downward, Eugenio Santos, Luis Miguel Pedrero Esteban, Matthias Drosten, Mariano Barbacid, Eleanor Y. M. Sum, Jelena Urosevic, Carmen Guerra, Carmen G. Lechuga and Miguel Murillo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.